Published Erratum
JAMA network open. 2026 Mar 2;9(3):e265966. DOI:10.1001/jamanetworkopen.2026.5966 2026
Preventing ARDS, Not Treating It-Lessons From Sivelestat After Cardiopulmonary Bypass [0.03%]
预防急性呼吸窘迫综合征(ARDS)，而非治疗——体外循环后西维莱司特的启示
Warren L Lee,Arthur S Slutsky
Warren L Lee
Early Morning Blood Draw Timing and Frequency Among Hospitalized Patients [0.03%]
住院患者的早期常规抽血的频率及时间分布特征分析
Michael Colacci,Anne Loffler,Surain B Roberts et al.
Michael Colacci et al.
Rachel Brown,Madeline DeMarco,Danielle Cullen
Rachel Brown
GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases [0.03%]
肠促胰素受体激动剂在2型糖尿病合并脑转移患者中的使用及其对预后的影响
Kuan-Yu Chi,Yu Chang,Junmin Song et al.
Kuan-Yu Chi et al.
Suspended Lead Suits and Radiation Exposure in Interventional Echocardiographers [0.03%]
悬吊式铅防护衣及介入性心脏超声医师的辐射暴露剂量分析
David A McNamara,Jeffrey M Decker,Michael W McNamara et al.
David A McNamara et al.
Importance: Percutaneous left atrial appendage occlusion (LAAO) is frequently performed with an interventional echocardiographer (IE) in close proximity to the patient and radiation source, increasing the risk for occupat...
Sivelestat and Incidence of Acute Respiratory Distress Syndrome After Cardiovascular Surgery: A Randomized Clinical Trial [0.03%]
斯维莱司特与心血管手术后急性呼吸窘迫综合征发生率的关系：随机临床试验
Tuo Pan,Can Xu,Ya-Peng Wang et al.
Tuo Pan et al.
Importance: Acute respiratory distress syndrome (ARDS) represents a frequent and serious complication after cardiovascular surgery. Although sivelestat, a specific neutrophil elastase inhibitor, has demonstrated therapeut...
Randomized Controlled Trial
JAMA network open. 2026 Mar 2;9(3):e260390. DOI:10.1001/jamanetworkopen.2026.0390 2026
HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of Precancer [0.03%]
人乳头瘤病毒、细胞学以及联合宫颈癌筛查与癌前病变风险的关系
Anna Gottschlich,Laurie W Smith,Quan Hong et al.
Anna Gottschlich et al.
Importance: There is a global call to end cervical cancer, and various jurisdictions are still determining optimal strategies to accelerate elimination. Human papillomavirus (HPV)-negative testing confers lower risk of fu...
Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant [0.03%]
APOL1肾脏病携带p.N264K M1保护变异的精准诊断方法
Elena Martinelli,Juntao Ke,Atlas Khan et al.
Elena Martinelli et al.
Importance: The APOL1 M1 (p.N264K) variant protects against G2-associated APOL1 focal segmental glomerulosclerosis (FSGS) and chronic kidney disease (CKD). However, the utility of knowing an individual's M1 status in guid...
Error in Affiliation [0.03%]
affiliation错误
Published Erratum
JAMA network open. 2026 Mar 2;9(3):e265103. DOI:10.1001/jamanetworkopen.2026.5103 2026